Clinical Trial Update: Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US [Phase 4]

View source ↗

Summary

A phase 4 trial comparing latanoprost with travoprost and bimatoprost in patients with elevated intraocular pressure, completed in the US.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (bimatoprost)
• Latanoprost (Latanoprost)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED